Literature DB >> 9294790

Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.

M H Chin1, J C Wang, J X Zhang, R M Lang.   

Abstract

To determine if physician specialty is associated with underutilization and underdosing of angiotensin-converting enzyme inhibitors among patients with heart failure, we reviewed the charts of 214 outpatients with decreased systolic function at an urban academic medical center. Regardless of whether patients were cared for by cardiologists, generalist physicians, or a combination of the two specialities, approximately 75% of the patients were taking an angiotensin-converting enzyme inhibitor. However, only approximately 60% of these patients were taking dosages proved to be efficacious in trials. Emphasis on adequate dosing is needed among all specialty groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294790      PMCID: PMC1497161          DOI: 10.1046/j.1525-1497.1997.07110.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

Review 1.  Knowledge, patterns of care, and outcomes of care for generalists and specialists.

Authors:  L R Harrold; T S Field; J H Gurwitz
Journal:  J Gen Intern Med       Date:  1999-08       Impact factor: 5.128

2.  Beyond us versus them.

Authors:  M S Klempner
Journal:  J Gen Intern Med       Date:  1999-08       Impact factor: 5.128

3.  Differences between generalists and specialists: knowledge, realism, or primum non nocere?

Authors:  B J Turner; C Laine
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

4.  Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?

Authors:  M A Scheiner; S E Kimmel
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

5.  In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure.

Authors:  Wilbert S Aronow; Michael W Rich; Sarah J Goodlin; Thomas Birkner; Yan Zhang; Margaret A Feller; Inmaculada B Aban; Linda G Jones; Donna M Bearden; Richard M Allman; Ali Ahmed
Journal:  J Am Med Dir Assoc       Date:  2011-10-08       Impact factor: 4.669

Review 6.  Lisinopril: a review of its use in congestive heart failure.

Authors:  K Simpson; B Jarvis
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

7.  Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.

Authors:  M H Chin; P D Friedmann; C K Cassel; R M Lang
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

Review 8.  Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.

Authors:  F Andersson; C Cline; T Rydén-Bergsten; L Erhardt
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

9.  Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community.

Authors:  Paula A Rochon; Kathy Sykora; Susan E Bronskill; Muhammad Mamdani; Geoffrey M Anderson; Jerry H Gurwitz; Sudeep Gill; Jack V Tu; Andreas Laupacis
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

10.  Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine.

Authors:  Waleed M Sweileh; Ansam F Sawalha; Tamara M Rinno; Sa'ed H Zyoud; Samah W Al-Jabi
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.